BRAIN PRINT

 

SCROLL

2018/02/01

  • Media Coverage

LPixel Featured as One of the 50 Most Promising Enterprise Startups in APAC CIOoutlook Magazine

Tokyo, Japan – February 1, 2018 – LPixel Inc., a leader in image processing and analysis technology in life science and medical research, has been featured in APAC CIOoutlook’s 50 Most Promising Enterprise Startups Special Edition, a publication that aims to connect CIOs, CTOs, and senior-level decision makers within the APAC countries with the newest solutions in trending technology. LPixel plans to expand and amplify its research and development efforts for its AI medical image diagnostic technology, EIRL, across Japan and globally.

The full version of the article can be viewed from here.


About LPixel
LPixel is a leader in advanced image analysis and processing technology encompassing the life science field. Founded in March 2014, LPixel is dedicated to offering research facilities top-tier image analysis technologies and medical diagnosis systems, both of which adopt advanced AI technology. The company is currently working with the National Cancer Center Japan and other research institutions to further the development of AI-based medical diagnosis software. For more information, please visit https://lpixel.net/en

PRODUCTS

EIRL
Cutting-Edge Technologies that Lead Future Medical Diagnosis
EIRL analyzes a wide range of medical data to provide an accurate and efficient diagnosis. EIRL aims to be the closest partner to all doctors, and serve as another powerful set of eyes to provide top quality medical care.
IMACEL
AI for accelerating
your research
IMACEL instantly processes and analyzes of a large volume of images, creating an environment that enables researchers to focus on their research. Extensive knowledge on image analysis technologies is not a requirement to get started with IMACEL.

JOINT RESEARCH

PARTNERS

Alphabetical listing

CAREERS

A Third Career Option for Researchers

LPIXEL Inc.